These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 12702905

  • 1. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

  • 2. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 10; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 4. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 10; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 5. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 10; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 10; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 7. [Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 10; 27(8):1264-6, 1270. PubMed ID: 17715044
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
    Husa P, Chalupa P, Stroblová H, Husová L, Slesinger P.
    Acta Virol; 2001 Aug 10; 45(5-6):293-7. PubMed ID: 12083328
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct 10; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH, Yu SK, Seo YS, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH, Byun KS.
    J Gastroenterol Hepatol; 2007 Aug 10; 22(8):1220-5. PubMed ID: 17532786
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
    Lazăr C, Grigorescu-Sido P, Manasia R, Mireştean S, Skorka C, Neculoiu D, Molnar G, Cocean S.
    Rom J Gastroenterol; 2005 Sep 10; 14(3):219-24. PubMed ID: 16200230
    [Abstract] [Full Text] [Related]

  • 12. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007 Sep 10; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH, Deng X, Chen XC, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 10; 21(1):62-3. PubMed ID: 17429539
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.
    Hepatology; 2004 Mar 10; 39(3):804-10. PubMed ID: 14999700
    [Abstract] [Full Text] [Related]

  • 15. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar 10; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of lamivudine in patients with hepatitis B e antigen-negative chronic liver diseases].
    Jeong Id, Park NH, Kim BC, Park JH, Seo KW, Kim DH, Joo KR, Kim DH.
    Taehan Kan Hakhoe Chi; 2003 Jun 10; 9(2):69-78. PubMed ID: 12824746
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug 10; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 18. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H, Zhao ZX, Xu QH, Zhou YP, Chen YM, Yao JL.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May 10; 11(5):305-8. PubMed ID: 12773249
    [Abstract] [Full Text] [Related]

  • 19. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G, Wang B, Cui Z, Yao J, Zeng M.
    Chin Med J (Engl); 1999 May 10; 112(5):387-91. PubMed ID: 11593504
    [Abstract] [Full Text] [Related]

  • 20. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 May 10; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.